Literature DB >> 26947703

Beyond the Condom: Frontiers in Male Contraception.

Mara Y Roth1, John K Amory1.   

Abstract

Nearly half of all pregnancies worldwide are unplanned, despite numerous contraceptive options available. No new contraceptive method has been developed for men since the invention of condom. Nevertheless, more than 25% of contraception worldwide relies on male methods. Therefore, novel effective methods of male contraception are of interest. Herein we review the physiologic basis for both male hormonal and nonhormonal methods of contraception. We review the history of male hormonal contraception development, current hormonal agents in development, as well as the potential risks and benefits of male hormonal contraception options for men. Nonhormonal methods reviewed will include both pharmacological and mechanical approaches in development, with specific focus on methods which inhibit the testicular retinoic acid synthesis and action. Multiple hormonal and nonhormonal methods of male contraception are in the drug development pathway, with the hope that a reversible, reliable, safe method of male contraception will be available to couples in the not too distant future. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 26947703      PMCID: PMC5107581          DOI: 10.1055/s-0036-1571435

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  87 in total

1.  Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

Authors:  Stephanie T Page; John K Amory; Bradley D Anawalt; Michael S Irwig; Andrew T Brockenbrough; Alvin M Matsumoto; William J Bremner
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

2.  Induced abortion: estimated rates and trends worldwide.

Authors:  Gilda Sedgh; Stanley Henshaw; Susheela Singh; Elisabeth Ahman; Iqbal H Shah
Journal:  Lancet       Date:  2007-10-13       Impact factor: 79.321

3.  Contraceptive failure rates in France: results from a population-based survey.

Authors:  C Moreau; J Trussell; G Rodriguez; N Bajos; J Bouyer
Journal:  Hum Reprod       Date:  2007-06-28       Impact factor: 6.918

4.  Nestorone: a progestin with a unique pharmacological profile.

Authors:  N Kumar; S S Koide; Y Tsong; K Sundaram
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

5.  Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.

Authors:  Lam P Ly; Peter Y Liu; David J Handelsman
Journal:  Hum Reprod       Date:  2005-04-28       Impact factor: 6.918

6.  Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis.

Authors:  John K Amory; Charles H Muller; Jakob A Shimshoni; Nina Isoherranen; Jisun Paik; Jan S Moreb; David W Amory; Ryan Evanoff; Alex S Goldstein; Michael D Griswold
Journal:  J Androl       Date:  2010-08-12

Review 7.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

8.  A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.

Authors:  Sigrid von Eckardstein; Gabriela Noe; Vivian Brache; Eberhard Nieschlag; Horacio Croxatto; Francisco Alvarez; Alfred Moo-Young; Irving Sivin; Narender Kumar; Margaret Small; Kalyan Sundaram
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

9.  A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

Authors:  Niloufar Ilani; Mara Y Roth; John K Amory; Ronald S Swerdloff; Clint Dart; Stephanie T Page; William J Bremner; Regine Sitruk-Ware; Narender Kumar; Diana L Blithe; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

10.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN.

Authors:  S B Wolbach; P R Howe
Journal:  J Exp Med       Date:  1925-11-30       Impact factor: 14.307

View more
  5 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  Current and future contraceptive options for women living with HIV.

Authors:  Rena C Patel; Elizabeth A Bukusi; Jared M Baeten
Journal:  Expert Opin Pharmacother       Date:  2017-09-19       Impact factor: 3.889

3.  Are men ready to use thermal male contraception? Acceptability in two French populations: New fathers and new providers.

Authors:  Marie Amouroux; Roger Mieusset; Raoul Desbriere; Pierre Opinel; Gilles Karsenty; Marine Paci; Sara Fernandes; Blandine Courbiere; Jeanne Perrin
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

Review 4.  The future of male contraception: a fertile ground.

Authors:  Iyad Khourdaji; Jacqueline Zillioux; Kevin Eisenfrats; Daniel Foley; Ryan Smith
Journal:  Transl Androl Urol       Date:  2018-05

5.  Discovery and Characterization of Multiple Classes of Human CatSper Blockers.

Authors:  Erick J Carlson; Rawle Francis; Yutong Liu; Ping Li; Maximilian Lyon; Celia M Santi; Derek J Hook; Jon E Hawkinson; Gunda I Georg
Journal:  ChemMedChem       Date:  2022-06-14       Impact factor: 3.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.